Danielle Brill
Stock Analyst at Raymond James
(0)
# 4261
Out of 5,245 analysts
88
Total ratings
30.77%
Success rate
-8.08%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
uniQure | Upgrades: Strong Buy | 20 52 | 14.07 | 269.58% | 6 | Dec 10, 2024 | |
Tectonic Therapeutic | Initiates Coverage On: Outperform | 65 | 41.04 | 58.38% | 1 | Nov 20, 2024 | |
Denali Therapeutics | Reinstates: Market Perform | n/a | n/a | n/a | 1 | Oct 10, 2024 | |
Biomarin Pharmaceuti... | Reinstates: Outperform | 79 | 61.45 | 28.56% | 1 | Oct 10, 2024 | |
Regenxbio | Reinstates: Outperform | 18 | 7.37 | 144.23% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 155 | 143.21 | 8.23% | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 36 | 23.86 | 50.88% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 40 | 39.14 | 2.2% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 150 | 117.92 | 27.2% | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Strong Buy | 605 | 640.27 | -5.51% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 50 | 38.55 | 29.7% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 51 | 32.44 | 57.21% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 43 | 58.18 | -26.09% | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 5 | 0.61 | 719.67% | 5 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 9 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 50 | n/a | n/a | 5 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 17, 2019 |